Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
Perez M, Adam A, Molinaro G Bradykinin, an important mediator of the cardiovascular effects of metallopeptidase inhibitors: experimental and clinical evidences Journal of Clinical and Basic Cardiology 2001; 4 (1): 39-46 PDF Summary Overview
| ||
Figure/Graphic 1: Bradykininmetabolismus Bradykinin metabolism and its relationship with two other vasoactive mediators: angiotensin and natriuretic peptides. ACE, angiotensin-converting enzyme; AI, angiotensin I; AII, angiotensin II; ANP, atrial natriuretic peptide; APP, aminopeptidase P; AT1, angiotensin II type I receptor; AT2, angiotensin II type II receptor; BK, bradykinin; BNP, brain natriuretic peptide; CNP, C-natruretic peptide; NEP, neutral endopeptidase 24.11; NPR-A, natriuretic peptide receptor type A; NPR-B, natriuretic peptide receptor type B. |
Figure/Graphic 1: Bradykininmetabolismus
Bradykinin metabolism and its relationship with two other vasoactive mediators: angiotensin and natriuretic peptides. ACE, angiotensin-converting enzyme; AI, angiotensin I; AII, angiotensin II; ANP, atrial natriuretic peptide; APP, aminopeptidase P; AT1, angiotensin II type I receptor; AT2, angiotensin II type II receptor; BK, bradykinin; BNP, brain natriuretic peptide; CNP, C-natruretic peptide; NEP, neutral endopeptidase 24.11; NPR-A, natriuretic peptide receptor type A; NPR-B, natriuretic peptide receptor type B. |